Glenmark’s current portfolio consists of 94 products authorized for distribution in the US marketplace and 72 ANDA’s pending approval with the USFDA. In addition to these internal filings, GGI continues to identify and explore external development partnerships to supplement and accelerate the growth of the existing pipeline and portfolio.
Real Time News & Trading Trends Keep Liking Epic Research Private Limited
For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co
No comments:
Post a Comment